Healthcare

Regard Clinical AI

AI that reads the entire patient chart to suggest diagnoses

Visit Regard Clinical AI
4.7rating25 viewsPricing · PaidHot
The Falcoscan Intel Panel/Regard Clinical AI · Healthcare
Live market data
Opportunity
88
Strong/ 100
Saturation
6
Open/ 100
Wrapper Risk
15
Open/ 100
Signal
Hot
Market trend
Rating
4.7
of 5 · 25 views
The Brief

What Regard Clinical AI does and why it matters

Regard continuously analyzes the full patient medical record and suggests potential diagnoses that physicians may have missed. The AI reduces diagnostic errors by surfacing patterns across the complete clinical history.

Builder’s Brief

Regard Clinical AI is a healthcare tool on Falcoscan. AI that reads the entire patient chart to suggest diagnoses. Falcoscan rates Regard Clinical AI with an Opportunity score of 88/100, a Saturation score of 6/100, and a Wrapper-risk score of 15/100. Market signal: hot. Regard Clinical AI is founded in 2019, currently at Seed stage. Pricing: Paid. Rating 4.7/5 across 25 tracked views.

What it ships with

Capabilities & who uses it

The capabilities Regard Clinical AI exposes to builders and the verticals it currently serves.

AI Capabilities
NlpClassificationData Extraction
Industry Verticals
HealthcareHospital Systems
Similar tools · Healthcare

Tools builders compare to Regard Clinical AI

The top-rated healthcare alternatives tracked on Falcoscan. Ranked by user rating within the category.

See the Healthcare market
Healthcare
DeepMind AlphaFold

AI protein structure prediction for drug discovery

4.9Opp 88
Free
Healthcare
Viz.ai Stroke AI

AI triage and coordination platform for stroke care

4.8Opp 88
Paid
Healthcare
Nuance DAX Copilot

AI clinical documentation assistant for physicians

4.8Opp 90
Paid
Healthcare
Viz.ai AI Stroke Response

AI stroke detection and care coordination platform

4.8Opp 90
Paid
Healthcare
Tempus AI Diagnostics

AI liquid biopsy analysis for early cancer detection

4.8Opp 88
Paid
Healthcare
Insilico Medicine

AI drug discovery platform for novel therapeutics

4.7Opp 88
Paid
Back to Browse